HomeComparePKANF vs JNJ

PKANF vs JNJ: Dividend Comparison 2026

PKANF yields 967.12% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKANF wins by $1.40M in total portfolio value
10 years
PKANF
PKANF
● Live price
967.12%
Share price
$0.21
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.43M
Annual income
$6,810.60
Full PKANF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PKANF vs JNJ

📍 PKANF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKANFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKANF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKANF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKANF
Annual income on $10K today (after 15% tax)
$82,205.03/yr
After 10yr DRIP, annual income (after tax)
$5,789.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, PKANF beats the other by $1,803.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKANF + JNJ for your $10,000?

PKANF: 50%JNJ: 50%
100% JNJ50/50100% PKANF
Portfolio after 10yr
$727.8K
Annual income
$5,750.00/yr
Blended yield
0.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PKANF
No analyst data
Altman Z
-0.2
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKANF buys
0
JNJ buys
0
No recent congressional trades found for PKANF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKANFJNJ
Forward yield967.12%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$1.43M$30.3K
Annual income after 10y$6,810.60$4,689.40
Total dividends collected$935.0K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PKANF vs JNJ ($10,000, DRIP)

YearPKANF PortfolioPKANF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$59,056$48,355.90$10,592$272.30+$48.5KPKANF
2$196,634$133,443.98$11,289$357.73+$185.3KPKANF
3$418,023$207,625.20$12,123$472.89+$405.9KPKANF
4$653,542$206,257.00$13,141$629.86+$640.4KPKANF
5$849,974$150,684.25$14,408$846.81+$835.6KPKANF
6$1,001,049$91,576.98$16,021$1,151.60+$985.0KPKANF
7$1,121,522$50,399.05$18,122$1,588.22+$1.10MPKANF
8$1,226,414$26,385.22$20,930$2,228.20+$1.21MPKANF
9$1,325,745$13,482.68$24,792$3,191.91+$1.30MPKANF
10$1,425,358$6,810.60$30,274$4,689.40+$1.40MPKANF

PKANF vs JNJ: Complete Analysis 2026

PKANFStock

Simply Better Brands Corp. manufactures and sells hemp-based cannabidiol related products in the United States. The company offers tinctures, topicals, capsules, gummies, pet tinctures and treats, bath bombs, pet wellness products, and skincare products comprising caffeine eye cream, retinol night cream, charcoal peel-off masks, moisturizers, serums, toner, cleanser, and acne patches. It also provides nutritious bars. The company offers its products under the PureKana, Tru Brand, BudaPets, and No BS brands. Simply Better Brands Corp. sells its products through its own e-commerce platforms, and brick and mortar retailers. The company was formerly known as PureK Holdings Corp. and changed its name to Simply Better Brands Corp. in May 2021. The company was founded in 2017 and is headquartered in Vancouver, Canada. Simply Better Brands Corp. is a subsidiary of Heavenly Rx Ltd.

Full PKANF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PKANF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKANF vs SCHDPKANF vs JEPIPKANF vs OPKANF vs KOPKANF vs MAINPKANF vs ABBVPKANF vs MRKPKANF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.